🇺🇸 FDA
Patent

US 7294344

Sustained-release preparation for AII antagonist, production and use thereof

granted A61KA61K31/00A61K31/4178

Quick answer

US patent 7294344 (Sustained-release preparation for AII antagonist, production and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/00, A61K31/4178, A61K31/4184, A61K9/1611